HopeStage
Back to all studies
RecruitingNCT05703256

Amygdala neurofeedback using positive memories for major depression

About this titleRead the official source — NCT05703256
Device studyAges 18–55United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

Listed locations
PittsburghSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 1, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
200
Sponsor
Kymberly Young
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT05703256
Official title
Show the full official title

Confirmatory Efficacy Randomized Clinical Trial of Amygdala Neurofeedback for Major Depressive Disorder

Recruitment & locations

Currently recruiting

Pittsburgh

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Kymberly Young.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies